Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Urology

Pd73-12 Pathologic Predictors of Muscle Invasive Urothelial Carcinoma of the Bladder Following Radical Nephroureterectomy

Journal of Urology

Urology

2017

English

Pd57-06 Altered Immune Cell Repertoire and Activity After Checkpoint Blockade Immunotherapy With Nivolumab in Renal Cell Carcinoma

Journal of Urology

Urology

2018

English

Pd04-08 Prognostic Significance of Tumor Extent Into the Venous System in Patients Undergoing Surgical Treatment for Renal Cell Carcinoma With Venous Tumor Thrombus

Journal of Urology

Urology

2016

English

Activation of the NLRP3 Inflammasome in Association With Calcium Oxalate Crystal Induced Reactive Oxygen Species in Kidneys

Journal of Urology

Urology

2015

English

Impact of the Number of Cycles of Platinum Based First Line Chemotherapy of Advanced Urothelial Carcinoma

Journal of Urology

Urology

2018

English

Mp58-05 the Long-Term Prognostic Value of Survivin Expressing Circulating Tumor Cells in Patients With High-Risk Non-Muscle Invasive Bladder Cancer (Nmibc)

Journal of Urology

Urology

2018

English

Mp57-19 the Influence of Board Certification on Outcomes After Radical Prostatectomy

Journal of Urology

Urology

2016

English

Mp30-18 Enhanced Atp Release and P2x1r Expression Contribute to Bladder Dysfunction in Type 2 Diabetes

Journal of Urology

Urology

2016

English

Pd42-10 Prognostic Value of Cell Cycle Progression Score in Prostate Cancer Patients With Locally Adverse Pathology After Radical Prostatectomy: Implications for Treatment Guidance

Journal of Urology

Urology

2018

English

Mp20-15 Comparison Between 68 Ga-Labelled Psma and 18 F-FDG Pet/Ct in the Diagnostic Value of Clear Cell Renal Cell Carcinoma

Journal of Urology

Urology

2018

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Urology

Pd73-12 Pathologic Predictors of Muscle Invasive Urothelial Carcinoma of the Bladder Following Radical Nephroureterectomy

Pd57-06 Altered Immune Cell Repertoire and Activity After Checkpoint Blockade Immunotherapy With Nivolumab in Renal Cell Carcinoma

Pd04-08 Prognostic Significance of Tumor Extent Into the Venous System in Patients Undergoing Surgical Treatment for Renal Cell Carcinoma With Venous Tumor Thrombus

Activation of the NLRP3 Inflammasome in Association With Calcium Oxalate Crystal Induced Reactive Oxygen Species in Kidneys

Impact of the Number of Cycles of Platinum Based First Line Chemotherapy of Advanced Urothelial Carcinoma

Mp58-05 the Long-Term Prognostic Value of Survivin Expressing Circulating Tumor Cells in Patients With High-Risk Non-Muscle Invasive Bladder Cancer (Nmibc)

Mp57-19 the Influence of Board Certification on Outcomes After Radical Prostatectomy

Mp30-18 Enhanced Atp Release and P2x1r Expression Contribute to Bladder Dysfunction in Type 2 Diabetes

Pd42-10 Prognostic Value of Cell Cycle Progression Score in Prostate Cancer Patients With Locally Adverse Pathology After Radical Prostatectomy: Implications for Treatment Guidance

Mp20-15 Comparison Between 68 Ga-Labelled Psma and 18 F-FDG Pet/Ct in the Diagnostic Value of Clear Cell Renal Cell Carcinoma